StockNews.com Begins Coverage on Aptose Biosciences (NASDAQ:APTO)
Equities researchers at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on APTO. Alliance Global Partners upgraded […]
Equities researchers at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on APTO. Alliance Global Partners upgraded […]
